Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma
Clinical trial NCT00311467 · TERMINATED
Trial details
- NCT number
- NCT00311467
- Sponsor
- Central European Cooperative Oncology Group
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2007-05-01
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.